AU Patent

AU2009308465B2 — Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors

Assigned to Array Biopharma Inc · Expires 2015-02-12 · 11y expired

What this patent protects

Compounds of Formula (I) in which R

USPTO Abstract

Compounds of Formula (I) in which R

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: AU2009308465B2
Jurisdiction: AU
Classification: —
Expires: 2015-02-12
Drug substance claim: No
Drug product claim: No
Assignee: Array Biopharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.